Article ID Journal Published Year Pages File Type
9321435 European Urology Supplements 2005 6 Pages PDF
Abstract
It is concluded that Eligard®, consisting of a novel delivery system with an improved pharmacokinetic profile compared with other existing depot formulations, leads to reliable and sustained testosterone suppression with a favourable side effect profile.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Eligard®: Pharmacokinetics, Effect on Testosterone and PSA Levels and Tolerability
Authors
,